1 |
Kalach, N., P.H. Benhamou, F. Campeotto, M. Bergeret, C. Doupont, and J. Raymond. 2001. Clarithromycin resistance and eradication of Helicobacter pylori in children. Antimicrob. Agents Chemother. 45, 2134-2135
DOI
ScienceOn
|
2 |
Mikula, M., A. Dzwonek, K. Jagusztyn-Krynicka, and J. Ostrowski. 2003. Quantitative detection for low levels of Helicobacter pylori infection in experimentally infected mice by real-time PCR. J. Microbiol. Meth. 55, 351-359
DOI
ScienceOn
|
3 |
Parsonnet, J., G.D. Friedman, D.P. Vandersteen, Y. Chang, J.H. Vogelman, N. Orentreich, and R.K. Sibley. 1991. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325, 1127-1131
DOI
PUBMED
ScienceOn
|
4 |
Xiang, Z., S. Censini, P.F. Bsyeli, Y. Chang, J.H. Vogelman, N. Orentrich, and R.K. Sibley. 1995. Analysis of expression of cagA and vacA virulence factors in 43 strains of Helicobacter pylorireveals that clinical isolates can be divided into two major types and that cagA is not necessary for expression of the vacuolating cytotoxin. Infec. Immum. 63, 94-98
|
5 |
Versalovic, J., M.S. Osato, K. Spakovsky, M.P. Dore, R. Reddy, G.G. Stone, D. Shortridge, R.K. Flamm, S.K. Tanaka, and D.Y. Graham. 1997. Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J. Antimicrob. Chemother. 40, 283-286
DOI
ScienceOn
|
6 |
Raymond, J., N. Kalach, M. Bergeret, P.H. Benhamou, J.P. Barbet, Gendrel, and C. Dupont. 1998. Effect of metronidazole resistance on bacterial eradication of Helicobacter pylori in infected children. Antimicrob. Agents Chemother. 42, 1334-1335
PUBMED
|
7 |
National Committee for Clinical Laboratory Standards (NCCLS). 1999. Performance standards for antimicrobial susceptibility testing. Ninth informational supplement M100-S9. Villanova, PA
|
8 |
Kim, J.H., H.Y. Kim, N.Y. Kim, S.W. Kim, J.G. Kim, J.J. Kim, J.K. Seo, J.G. Sim, I.H. Roe, H.S. Ahn, B.C. Yoon, S.W. Lee, Y.C. Lee, I.S. Chung, H.Y. Jung, W.S. Hong, and K.W. Choi. 2000. Seroprevalence of Helicobacter pylori infection in asymptomatic people in Korea. Kor. J. Med. 59, 388-397
|
9 |
Taylor, D.E., M. Eaton, N. Chang, and S.M. Salama. 1992. Construction of Helicobacter pylori genome map and demonstration of diversity at the genome level. J. Bacteriol. 174, 6800-6806
DOI
PUBMED
|
10 |
Toracchio, S., L. Cellini, D.I. Campli, G. Cappello, M.G. Malatesta, A. Ferri, A.F. Ciccaglione, L. Grossi, and L. Marzio. 2000. Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. Aliment. Pharmacol. Ther. 14, 1639-1643
DOI
ScienceOn
|
11 |
Shin, J.-H., M. Yang, S.W. Nam, J.T. Kim, N.H. Myung, W.-G. Bang, and I.H. Roe. 2002. Use of egg yolk-derived immunoglobulin as an alternative to antibiotic treatment for control of Helicobacter pylori infection. Clin. Diagn. Lab. Immunol. 9, 1061-1066
PUBMED
|
12 |
Wolle, K., M. Nilius, A. Leodolter, W.A. Muller, P. Malfertheiner, and W. Koning. 1998. Prevalence of Helicobacter pylori resistance to several antimicrobial agents in a region of Germany. Eur. J. Clin. Microbiol. Infect. Dis. 17, 519-521
|
13 |
Graham, D.Y. and W.A. Qureshi. 2000. Antibiotic-resistant H. pylori infection and its treatment. Curr. Pharm. Des. 15, 1537-1544
|
14 |
Dore, M.P., G. Leandro, G. Realdi, A.R. Sepulveda, and D.Y. Graham. 2000. Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pyloritherapy. Dig. Dis. Sci. 45, 68-76
DOI
ScienceOn
|
15 |
Toracchio, S. and L. Marzio. 2003. Primary and secondary antibiotic resistance of Helicobacter pylori strains in central Italy during the years 1998-2002. Dig. Liver Dis. 35, 541-545
DOI
ScienceOn
|
16 |
NIH Consensus Conference. 1994. Helicobacter pylori in peptic ulcer disease. NIH consensus development panel on Helicobacter pylori in peptic ulcer disease. J. Am. Med. Assoc. 272, 65-69
DOI
PUBMED
|
17 |
Tucci, A., O. Varoli, R. Corinaldesi, V. Stanghellini, S. Gasperoni, G.F. Paparo, M. Ricci-Maccarini, M. La Placa, and L. Barbara. 1993. Evaluation of Helicobacter pylori sensitivity to amoxicillin and metronidazole in dyspeptic patients. Ital. J. Gastroenterol. 25, 65-67
PUBMED
|
18 |
van Doorn, L.-J., Y. Glupczinski, J.G. Kusters, F. Mégraud, P. Midolo, N. Maggi-Solcà, D.M.M. Queiroz, N. Nouhan, E. Stet, and W.G.V. Quint. 2001. Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob. Agents Chemother. 45, 1500-1504
DOI
ScienceOn
|
19 |
Wang, G.E., M.S. Rahman, M.Z. Humayun, and D.E. Raylor. Multiplex sequence analysis demonstrates the competitive growth advantage of the A-to-G mutants of clarithromycin-resistant Helicobacter pylori. Antimicrob. Agents Chemother. 43, 683-685
|
20 |
Pilotto, A., M. Rassu, G. Leandro, M. Franceschi, and F.Di Mario. 2000. Prevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: a multicentre study. Dig. Liver Dis. 32, 763-768
DOI
ScienceOn
|
21 |
Debets-Ossenknopp, Y.J., A.J. Herscheid, R.G. Pot, E.J. Kuipers, J.G. Kusters, and C.M. Vandenbroucke-Grauls. 1999. Prevelence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and trovafloxacin in The Netherlands. J. Antimicrob. Chemother. 43, 511-515
DOI
ScienceOn
|
22 |
Drumm, B.S., S. Koletzko, and G. Oderda, on behalf of the European Pediatric Task Force on Helicobacter pylori. 2001. Helicobacter pylori infection in children: a consensus statement. J. Pediatr. Gastroenterol. Nutr. 30, 207-213
DOI
ScienceOn
|
23 |
Warren, J.R. and B.J. Marshall. 1983. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1, 1273-1275
PUBMED
|